Neomycin-BSA is a conjugate of Neomycin (HY-150520) and BSA. By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells[1].
Target:
Biochemical Assay Reagents
Application Notes:
MCE Product type: Biochemical Assay Reagents
* VAT and and shipping costs not included. Errors and price changes excepted
